Sign in
Taking peopleNo phase

Prospective Cohort Study of Patients Undergoing Coronary Angiography in Vorarlberg, Austria

Key facts

Who runs it
Vorarlberg Institute for Vascular Investigation and Treatment
Where
Austria1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
2,000 people, planned
Started
24 Mar 2022
Expected to end
31 Dec 2038
Type of study
Observational
Treatments tested
  • Coronary Angiography
Record updated
12 November 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Age ≥18 years
  • Clinically indicated coronary angiography for the evaluation of suspected or established stable coronary artery disease at Feldkirch Regional Hospital, Austria
  • Written informed consent to participate in the study after receiving comprehensive information about the study

Who cannot take part

  • Known current alcohol or illicit drug abuse that, in the investigator's judgment, may compromise participant safety or compliance
  • Acute coronary syndrome
  • Age under 18 years
  • Pregnancy
  • Individuals detained by order of a judicial or administrative authority
  • Close relationship with the study site, including relatives of investigators or individuals in a dependent relationship with study personnel
  • Inability to understand and sign the informed consent form

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This prospective observational cohort study investigates cardiovascular outcomes and associated risk factors in patients undergoing coronary angiography for suspected or established coronary artery disease at Feldkirch Regional Hospital in Vorarlberg, Austria.

Read full original descriptionShow less

The study aims to identify clinical, metabolic, laboratory, and lifestyle factors associated with coronary artery disease and subsequent cardiovascular events. Baseline assessments include clinical characteristics, cardiovascular risk factors, laboratory measurements, and lifestyle-related information.

The primary outcomes are all-cause mortality and cardiovascular events. Follow-up assessments are conducted approximately every two years through telephone interviews and review of available clinical records and databases. Mortality status and causes of death are assessed using data from Statistics Austria and available medical records. Long-term follow-up is planned to evaluate cardiovascular outcomes and changes in risk factors over time.

The study aims to enroll approximately 2,000 participants, with recruitment ongoing.

The group in the trial

  • Patients Undergoing Coronary Angiography

    Adult patients undergoing clinically indicated coronary angiography for suspected or established stable coronary artery disease at Feldkirch Regional Hospital, Austria. Baseline clinical and laboratory assessments are performed at enrollment. Participants are prospectively followed to evaluate all-cause mortality, cardiovascular events, and associated risk factors. Follow-up data are collected through telephone interviews and queries of relevant clinical and administrative databases.

    Treatment: Coronary Angiography

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Record updated
12 November 2026